Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001295101 | SCV001484012 | uncertain significance | Nephronophthisis | 2022-03-03 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 39 of the NPHP3 protein (p.Arg39Leu). This variant is present in population databases (rs753467164, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with NPHP3-related conditions. ClinVar contains an entry for this variant (Variation ID: 999142). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002499540 | SCV002793276 | uncertain significance | Renal-hepatic-pancreatic dysplasia 1; Nephronophthisis 3; NPHP3-related Meckel-like syndrome | 2024-04-04 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004531075 | SCV004114253 | uncertain significance | NPHP3-related disorder | 2023-03-14 | criteria provided, single submitter | clinical testing | The NPHP3 c.116G>T variant is predicted to result in the amino acid substitution p.Arg39Leu. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.021% of alleles in individuals of East Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/3-132441084-C-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |